Drug InteractionsPK Enhancers

• PI in combination with potent metabolic inhibitor (e.g., low dose ritonavir)

• Intent: increase concentrations of PI, not antiviral efficacy of 2nd drug

• Alter dosing regimen for PI

• Exposure measures may be quite different from approved regimens

Previous slide

Next slide

Back to first slide

View graphic version